The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Sponsor
Sindh Institute of Urology and Transplantation (Other)
Overall Status
Completed
CT.gov ID
NCT05463276
Collaborator
(none)
690
1
2
338.7
Study Details
Study Description
Brief Summary
This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
690 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Actual Study Start Date
:
Feb 28, 2022
Actual Primary Completion Date
:
May 1, 2022
Actual Study Completion Date
:
May 1, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with breast cancer
|
Outcome Measures
Primary Outcome Measures
- Demographic characteristics of patients with breast cancer [At the time of presentation]
age, gender, residence, marital status
- Risk factors of patients with breast cancer [At the time of presentation]
age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index
- Clinical presentation of patients with breast cancer [At the time of presentation]
site and duration
- Stage of the breast cancer [At the time of presentation]
American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer
- Histopathological characteristics of patients with breast cancer [At the time of presentation]
tumor type, hormone receptor status, Ki-67, and grade
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients diagnosed with breast cancer
Exclusion Criteria:
- The patients that were lost to follow-up after the first consultation and those consulting for a second opinion were excluded from the study.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sindh Institute of Urology and Transplantation | Karachi | Sindh | Pakistan |
Sponsors and Collaborators
- Sindh Institute of Urology and Transplantation
Investigators
- Principal Investigator: Murk Niaz, Sindh Institute of Urology and Transplantation
- Principal Investigator: Bushra Shirazi, Sindh Institute of Urology and Transplantation
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Murk Niaz,
Medical Officer,
Sindh Institute of Urology and Transplantation
ClinicalTrials.gov Identifier:
NCT05463276
Other Study ID Numbers:
- Breast Audit
First Posted:
Jul 18, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Murk Niaz,
Medical Officer,
Sindh Institute of Urology and Transplantation
Additional relevant MeSH terms: